(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 6.18% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.2%.
Apyx Medical's revenue in 2024 is $49,031,000.On average, 1 Wall Street analysts forecast APYX's revenue for 2024 to be $1,768,572,422, with the lowest APYX revenue forecast at $1,768,572,422, and the highest APYX revenue forecast at $1,768,572,422. On average, 1 Wall Street analysts forecast APYX's revenue for 2025 to be $1,887,747,528, with the lowest APYX revenue forecast at $1,887,747,528, and the highest APYX revenue forecast at $1,887,747,528.
In 2026, APYX is forecast to generate $2,089,028,738 in revenue, with the lowest revenue forecast at $2,089,028,738 and the highest revenue forecast at $2,089,028,738.